Suven Life Sciences Ltd. | Mutual Funds
Mutual Funds that own Suven Life Sciences Ltd.
Birla Sun Life Pure Value Fund
1,063,000
0.84%
0
0.72%
07/31/2018
436,764
0.34%
0
0.79%
09/05/2018
SBI Life Daily Protect Fund III
420,295
0.33%
2,082
0.18%
12/31/2017
DFA Emerging Markets Core Equity Portfolio
257,482
0.2%
3,311
0%
04/30/2018
DFA Emerging Markets Small Cap Series
243,810
0.19%
104,608
0.01%
01/31/2018
L&T Emerging Businesses Fund
222,646
0.18%
222,646
0.12%
07/31/2018
187,000
0.15%
187,000
2.31%
07/31/2018
LIC Nomura MF Balanced Fund
173,050
0.14%
0
1.75%
08/31/2018
170,000
0.13%
170,000
1.15%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
145,806
0.12%
0
0.01%
09/05/2018
| Address |
6th Floor, SDE Serene Chambers
Hyderabad TS 500034
India
|
|
Employees
|
- |
| Website |
http://www.suven.com |
| Updated |
09/14/2018 |
| Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. It operates through the following segments: Manufacturing, Services, and Research & Development. The Manufacturing segment consists of bulk drugs and intermediates under contract services products are developed and produced on an exclusive basis. |
